THE Therapeutic Goods Administration has issued an alert advising consumers and health professionals that Lose Weight capsules pose a serious health risk and contain sibutramine, a prescription-only medicine which was the active ingredient in Reductil, and the NSAID diclofenac.
Reductil was withdrawn in Oct 2010 after a study showed an increased risk of major cardiac events.
Visit tga.gov.au for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Apr 17
